Showing results (21-30 of 351) with videos related to
Sort By:
Pageof 36
Cancer Letters|July 26, 2015
mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cellsGovindasamy-Muralidharan Karthik, Ran Ma, John Lövrot, et al.Molecular Oncology|March 9, 2023
The interplay between eosinophils and T cells in breast cancer immunotherapyIoannis Zerdes, Alexios Matikas, Theodoros FoukakisLakartidningen|February 22, 2017
[Worse prognosis for young women with breast cancer]Irma Fredriksson, Hanna FredholmJapanese Journal of Radiology|January 10, 2025
AI image analysis as the basis for risk-stratified screeningFredrik StrandThe Lancet Regional Health. Europe|October 13, 2025
Prevalence and prognosis of patients with breast cancer eligible for adjuvant abemaciclib or ribociclib: a nationwide population-based studyXingrong Liu, Behnaz Binicy, Balazs Acs, et al.Expert Review of Anticancer Therapy|January 28, 2017
Implementing neoadjuvant endocrine strategies in ER-positive, HER2-negative breast cancerAlexios Matikas, Theodoros Foukakis, Ilias Michalakis, et al.Eclinicalmedicine|November 3, 2025
Adherence to adjuvant endocrine therapy including GnRH-analogues and survival: a population-based cohort studyLouise Eriksson Bergman, Alexios Matikas, Xingrong Liu, et al.Cancers|June 10, 2022
Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter StudyUna Kjällquist, Balazs Acs, Sara Margolin, et al.Acta Oncologica (Stockholm, Sweden)|April 24, 2007
Advances in the treatment of patients with gastric adenocarcinomaTheodoros Foukakis, Lars Lundell, Michael Gubanski, et al.Scientific Reports|December 1, 2016
Sequencing-based breast cancer diagnostics as an alternative to routine biomarkersMattias Rantalainen, Daniel Klevebring, Johan Lindberg, et al.Pageof 36